Stuhr, L.K.; Madsen, K.; Johansen, A.Z.; Chen, I.M.; Hansen, C.P.; Jensen, L.H.; Hansen, T.F.; Kløve-Mogensen, K.; Nielsen, K.R.; Johansen, J.S.
Combining sCD163 with CA 19-9 Increases the Predictiveness of Pancreatic Ductal Adenocarcinoma. Cancers 2023, 15, 897.
https://doi.org/10.3390/cancers15030897
AMA Style
Stuhr LK, Madsen K, Johansen AZ, Chen IM, Hansen CP, Jensen LH, Hansen TF, Kløve-Mogensen K, Nielsen KR, Johansen JS.
Combining sCD163 with CA 19-9 Increases the Predictiveness of Pancreatic Ductal Adenocarcinoma. Cancers. 2023; 15(3):897.
https://doi.org/10.3390/cancers15030897
Chicago/Turabian Style
Stuhr, Liva K., Kasper Madsen, Astrid Z. Johansen, Inna M. Chen, Carsten P. Hansen, Lars H. Jensen, Torben F. Hansen, Kirstine Kløve-Mogensen, Kaspar R. Nielsen, and Julia S. Johansen.
2023. "Combining sCD163 with CA 19-9 Increases the Predictiveness of Pancreatic Ductal Adenocarcinoma" Cancers 15, no. 3: 897.
https://doi.org/10.3390/cancers15030897
APA Style
Stuhr, L. K., Madsen, K., Johansen, A. Z., Chen, I. M., Hansen, C. P., Jensen, L. H., Hansen, T. F., Kløve-Mogensen, K., Nielsen, K. R., & Johansen, J. S.
(2023). Combining sCD163 with CA 19-9 Increases the Predictiveness of Pancreatic Ductal Adenocarcinoma. Cancers, 15(3), 897.
https://doi.org/10.3390/cancers15030897